Kowalsky Matthew Paul - Insider Non-Derivative Transactions at Sigilon Therapeutics, Inc. (SGTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 11, 2023, Kowalsky Matthew Paul's relationship to Sigilon Therapeutics, Inc. (SGTX) is Officer (CHIEF OF STAFF AND CLO), and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SGTX insiders.
Data Source: SEC.
Kowalsky Matthew Paul - Insider Non-Derivative Transactions at SGTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 12, 2023 | Disposition -- (Common Stock) | 1925 | 0 | 0 |